Waldron Private Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.37M | Sell |
29,274
-340
| -1% | -$73.2K | 0.26% | 47 |
|
|
2026
Q1 | $6.44M | Buy |
29,614
+541
| +2% | +$120K | 0.25% | 46 |
|
|
2025
Q4 | $6.64M | Buy |
29,073
+502
| +2% | +$114K | 0.26% | 49 |
|
|
2025
Q3 | $6.62M | Buy |
28,571
+632
| +2% | +$129K | 0.27% | 48 |
|
|
2025
Q2 | $5.19M | Sell |
27,939
-216
| -0.8% | -$40.1K | 0.23% | 54 |
|
|
2025
Q1 | $5.9M | Sell |
28,155
-9,447
| -25% | -$1.84M | 0.28% | 46 |
|
|
2024
Q4 | $6.68M | Buy |
37,602
+3,930
| +12% | +$723K | 0.27% | 52 |
|
|
2024
Q3 | $6.65M | Buy |
33,672
+867
| +3% | +$162K | 0.28% | 50 |
|
|
2024
Q2 | $5.63M | Buy |
32,805
+115
| +0.4% | +$19.1K | 0.25% | 56 |
|
|
2024
Q1 | $5.95M | Buy |
32,690
+1,029
| +3% | +$177K | 0.27% | 52 |
|
|
2023
Q4 | $4.91M | Sell |
31,661
-502
| -2% | -$73.2K | 0.23% | 55 |
|
|
2023
Q3 | $4.79M | Buy |
32,163
+922
| +3% | +$135K | 0.25% | 53 |
|
|
2023
Q2 | $4.21M | Sell |
31,241
-5,772
| -16% | -$846K | 0.21% | 60 |
|
|
2023
Q1 | $5.9M | Buy |
37,013
+7,163
| +24% | +$1.1M | 0.29% | 50 |
|
|
2022
Q4 | $4.01M | Hold |
29,850
| – | – | 0.25% | 63 |
|
|
2022
Q3 | $4.01M | Buy |
29,850
+486
| +2% | +$69.7K | 0.25% | 63 |
|
|
2022
Q2 | $4.5M | Buy |
29,364
+1,044
| +4% | +$160K | 0.25% | 59 |
|
|
2022
Q1 | $4.59M | Buy |
28,320
+374
| +1% | +$54.3K | 0.24% | 65 |
|
|
2021
Q4 | $3.78M | Buy |
27,946
+62
| +0.2% | +$7.32K | 0.19% | 77 |
|
|
2021
Q3 | $3.01M | Buy |
27,884
+2,017
| +8% | +$230K | 0.18% | 77 |
|
|
2021
Q2 | $2.91M | Buy |
25,867
+117
| +0.5% | +$13.2K | 0.19% | 73 |
|
|
2021
Q1 | $2.79M | Sell |
25,750
-109
| -0.4% | -$11.7K | 0.19% | 71 |
|
|
2020
Q4 | $2.77M | Buy |
25,859
+657
| +3% | +$63.1K | 0.21% | 66 |
|
|
2020
Q3 | $2.21M | Buy |
25,202
+844
| +3% | +$79.5K | 0.19% | 72 |
|
|
2020
Q2 | $2.39M | Sell |
24,358
-6,781
| -22% | -$597K | 0.21% | 66 |
|
|
2020
Q1 | $2.37M | Sell |
31,139
-1,336
| -4% | -$114K | 0.25% | 65 |
|
|
2019
Q4 | $2.88M | Buy |
32,475
+114
| +0.4% | +$9.46K | 0.26% | 59 |
|
|
2019
Q3 | $2.45M | Buy |
32,361
+25,204
| +352% | +$1.73M | 0.25% | 58 |
|
|
2019
Q2 | $520K | Sell |
7,157
-1,510
| -17% | -$119K | 0.06% | 134 |
|
|
2019
Q1 | $698K | Buy |
8,667
+1,745
| +25% | +$143K | 0.08% | 115 |
|
|
2018
Q4 | $638K | Buy |
6,922
+1,297
| +23% | +$114K | 0.09% | 102 |
|
|
2018
Q3 | $532K | Buy |
5,625
+44
| +0.8% | +$4.17K | 0.1% | 96 |
|
|
2018
Q2 | $517K | Buy |
5,581
+41
| +0.7% | +$4K | 0.11% | 87 |
|
|
2018
Q1 | $524K | Hold |
5,540
| – | – | 0.12% | 80 |
|
|
2017
Q4 | $535K | Hold |
5,540
| – | – | 0.13% | 76 |
|
|
2017
Q3 | $492K | Buy |
5,540
+150
| +3% | +$11.4K | 0.14% | 74 |
|
|
2017
Q2 | $390K | Sell |
5,390
-1,594
| -23% | -$107K | 0.12% | 73 |
|
|
2017
Q1 | $446K | Buy |
6,984
+1,653
| +31% | +$104K | 0.11% | 113 |
|
|
2016
Q4 | $333K | Buy |
5,331
+81
| +2% | +$4.94K | 0.11% | 83 |
|
|
2016
Q3 | $331K | Buy |
5,250
+115
| +2% | +$7.45K | 0.12% | 84 |
|
|
2016
Q2 | $317K | Sell |
5,135
-591
| -10% | -$36K | 0.12% | 93 |
|
|
2016
Q1 | $327K | Buy |
5,726
+103
| +2% | +$5.74K | 0.12% | 85 |
|
|
2015
Q4 | $333K | Buy |
5,623
+458
| +9% | +$26.4K | 0.12% | 96 |
|
|
2015
Q3 | $281K | Sell |
5,165
-843
| -14% | -$54.9K | 0.12% | 88 |
|
|
2015
Q2 | $403K | Sell |
6,008
-357
| -6% | -$23.3K | 0.16% | 52 |
|
|
2015
Q1 | $373K | Buy |
6,365
+2,595
| +69% | +$157K | 0.15% | 56 |
|
|
2014
Q4 | $247K | Buy |
3,770
+17
| +0.5% | +$1.07K | 0.1% | 94 |
|
|
2014
Q3 | $216K | Buy |
3,753
+70
| +2% | +$3.89K | 0.1% | 100 |
|
|
2014
Q2 | $208K | Buy |
+3,683
| New | +$193K | 0.1% | 115 |
|
Other funds holding ABBV
Waldron Private Wealth's ABBV Position: Q2 2026 in Review
Waldron Private Wealth reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $73.2K and leaving 29,274 shares worth $7.37M. The position accounts for 0.26% of the portfolio, ranked #47.
Waldron Private Wealth first reported a position in ABBV in Q2 2014 and has held it in 49 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Waldron Private Wealth held 29,274 shares of AbbVie worth $7.37M as of Q2 2026.
- Waldron Private Wealth sold 340 AbbVie shares in Q2 2026, an estimated $73.2K.
- AbbVie made up 0.26% of Waldron Private Wealth's portfolio in Q2 2026, its #47 holding.
- Waldron Private Wealth first reported a position in AbbVie in Q2 2014 and has held it in 49 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.